S267: PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND EFFICACY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE AGED 12 TO <18 YEARS: 2-YEAR DATA FROM THE PHASE 2 SOLACE-KIDS STUDY

oleh: Matthew Heeney1, David Rees, Mariane de Montalembert, Isaac Odame, Yasser Wali, Sarfaraz Sayyed, Velusamy Shanmuganathan Muthusamy, Anisha E. Mendonza, Michele Nassin, Deborah Keefe, Julie Kanter